Proteinea Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $6.5M

  • Investors
  • 23

Proteinea General Information

Description

Developer of a protein engineering platform designed to engineer next-generation antibodies with improved efficacy, safety, and convenience. The company's platform utilizes proprietary artificial intelligence models and computational tools to evaluate the efficacy, yield, safety, and pharmacological properties of biologics, enabling clients to design antibody medicines and focusing on scalable, sustainable, and cost-effective protein production.

Contact Information

Website
www.proteinea.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 700 main Street
  • Cambridge, MA 02139
  • United States
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • 700 main Street
  • Cambridge, MA 02139
  • United States

Proteinea Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Proteinea Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Seed Round 01-Jun-2025 $6.5M Completed Generating Revenue
10. Seed Round 01-Jan-2024 Completed Generating Revenue
9. Seed Round 22-Aug-2023 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
7. Seed Round 26-Feb-2021 Completed Generating Revenue
6. Accelerator/Incubator 01-Feb-2021 Completed Generating Revenue
5. Seed Round 01-Jan-2020 Completed Generating Revenue
4. Accelerator/Incubator 09-Jul-2019 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
To view Proteinea’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Proteinea Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Proteinea Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026188168-A1 Fc variants with enhanced serum half-life and improved developability properties Pending 06-Mar-2025
WO-2025128647-A1 Aa2dna: pre-trained amino acid-to-dna sequence mapping enabling efficient expression and yield optimization Inactive 11-Dec-2023
US-20250046397-A1 Genecull: enabling high-quality gene sequence modeling via evolution-guided data pruning criteria Inactive 03-Aug-2023
WO-2025030168-A1 Genecull: enabling high-quality gene sequence modeling via evolution-guided data pruning criteria Inactive 03-Aug-2023
WO-2025015093-A1 Aa2cds: pre-trained amino acid-to-codon sequence mapping enabling efficient expression and yield optimization Inactive 10-Jul-2023 G06N3/123
To view Proteinea’s complete patent history, request access »

Proteinea Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Proteinea Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
Logos Capital Hedge Fund Minority
Globivest Venture Capital Minority
ICLUB Angel Group Minority
Kerna Ventures Venture Capital Minority
Sadu Capital Venture Capital Minority
You’re viewing 5 of 23 investors. Get the full list »

Ready to get started?

Request a free trial

Proteinea FAQs

  • When was Proteinea founded?

    Proteinea was founded in 2019.

  • Where is Proteinea headquartered?

    Proteinea is headquartered in Cambridge, MA.

  • What is the size of Proteinea?

    Proteinea has 50 total employees.

  • What industry is Proteinea in?

    Proteinea’s primary industry is Other Healthcare Technology Systems.

  • Is Proteinea a private or public company?

    Proteinea is a Private company.

  • What is Proteinea’s current revenue?

    The current revenue for Proteinea is .

  • How much funding has Proteinea raised over time?

    Proteinea has raised $10.1M.

  • Who are Proteinea’s investors?

    Logos Capital, Globivest, ICLUB, Kerna Ventures, and Sadu Capital are 5 of 23 investors who have invested in Proteinea.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process